Discovery Proteomics

Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease

Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease

Discovery Proteomics
Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Discovery Proteomics
Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease

Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease

Discovery Proteomics Uncategorized
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease

Discovery Proteomics
Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level

Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level

Discovery Proteomics
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease

Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease

Discovery Proteomics
Sex differences in brain protein expression and disease

Sex differences in brain protein expression and disease

Discovery Proteomics
Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment

Unbiased classification of the elderly human brain proteome resolves distinct clinical and pathophysiological subtypes of cognitive impairment

Discovery Proteomics
Quantitative Analysis of the Brain Ubiquitylome in Alzheimer’s Disease

Quantitative Analysis of the Brain Ubiquitylome in Alzheimer’s Disease

Discovery Proteomics
Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease

Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease

Discovery Proteomics